HealthMap

Triamcinolone Joint Injections and Articular Cartilage

Overview

• Intra-articular corticosteroid injections, such as triamcinolone, are frequently used to reduce joint inflammation and pain.
• Based on biochemical and clinical data, frequent or high-dose corticosteroid injections can indeed pose significant risks to local articular cartilage.

Potential Mechanisms of Cartilage Damage

• Chondrocyte Toxicity: Corticosteroids can have a direct toxic effect on chondrocytes (cartilage-forming cells), inhibiting their metabolic activity, collagen synthesis, and matrix repair.
• Inhibition of Matrix Synthesis: They suppress the production of proteoglycans and collagen, which are essential for maintaining the shock-absorbing properties of cartilage.
• Accelerated Degeneration: Over time, repeated inhibition of these repair mechanisms can lead to a net loss of cartilage thickness, potentially accelerating the progression of osteoarthritis.
• Neuropathic-Like Arthropathy: In severe cases, overuse can contribute to rapid joint destruction, sometimes referred to as steroid-induced arthropathy.

Clinical Recommendations

• Limitation of Frequency: To minimize the risk of cartilage degradation, injections into the same joint are typically restricted in frequency (often allowing several months between treatments).
• Individual Assessment: The potential short-term relief of inflammation must be carefully weighed against the long-term structural risks to the joint cartilage, especially in weight-bearing joints like the knee or hip.